ClinicalTrials.Veeva

Menu

Fitness Level in Short Stature Children and After Growth Hormone Treatment

Clalit Health Services logo

Clalit Health Services

Status

Unknown

Conditions

Fitness

Treatments

Other: change in fitness level

Study type

Observational

Funder types

Other

Identifiers

NCT02977091
0258-16-MMC

Details and patient eligibility

About

fitness and Physical activity will be evaluate in short stature children, using the Euro Fitness testing and the Wingate anaerobic test. the fitness level will be evaluate in healthy short children and with growth hormone deficiency at base line and after 6 month .

Full description

The Euro Fitness testing which is a series of field testing for children evaluating aerobic, strength and flexibility and the Wingate anaerobic test which is a 30 seconds maximum pedaling against resistance on bike for evaluating the anaerobic fitness.

the fitness test will be done in healthy short stature children and in growth hormone deficiency or idiopathic short stature from the endocrine unit in Meir medical center The test will be done at base line and after 6 month . The fitness test in child with growth hormone deficiency will be done before starting GH treatment and 6 month later.

The child will be asked to fill a questioner about his daily physical activity Anthropometric measurement will be taking including weight, height and fat percent. Details about age, sex, tanner stage, indication for growth hormone, dose, insulin growth factor-1 (IGF1) level will be taken from the medical file.

Enrollment

50 estimated patients

Sex

All

Ages

5 to 17 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • short stature
  • Physical healthy
  • Mental healthy
  • Capable to perform fitness test

Exclusion criteria

  • Cardiac disease that interfere or risk the child during physical activity
  • Respiratory disease that interfere or risk the child during physical activity
  • Musculoskeletal disease interfering physical preformance.
  • Family history of death for unknown reasons at an early age.
  • Uncontroled thyroid diseae

Trial design

50 participants in 2 patient groups

GH deficiency or idiopathic short stature
Description:
growth hormone (GH) deficiency or idiopathic short stature children before they start GH treatment
Treatment:
Other: change in fitness level
short stature
Description:
healthy short children
Treatment:
Other: change in fitness level

Trial contacts and locations

1

Loading...

Central trial contact

Nitsan Dror, MD; Michal Pantanowitz, PHD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems